Medical Journals

Hyperinsulinemia: Effect on Cardiac Mass/Function, Angiotensin Ii Receptor Expression, and Insulin Signaling Pathways.

Authors:
  • Samuelsson Anne-Maj
  • Bollano Entela
  • Mobini Reza
  • Larsson Britt-Mari
  • Omerovic Elmir
  • Fu Michael
  • Waagstein Finn
  • Holmäng Agneta

From: Cardiovascular Institute, The Wallenberg Laboratory, Sahlgrenska Univ. Hospital, Göteborg University, S-413 45 Göteborg, Sweden. anne-maj.samuelsson@wlab.gu.se

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Aug 2006
  • ISSN: 0363-6135
  • Volume: 291
  • Issue: 2
  • Pages: H787-96
  • Medium: Print
  • Language: English
  • Citation (JAMA): Samuelsson Anne-Maj, Bollano Entela, Mobini Reza, et al. Hyperinsulinemia: Effect on Cardiac Mass/Function, Angiotensin Ii Receptor Expression, and Insulin Signaling Pathways.. Am. J. Physiol. Heart Circ. Physiol. Aug 2006;291:H787-96

Abstract

To investigate the association between hyperinsulinemia and cardiac hypertrophy, we treated rats with insulin for 7 wk and assessed effects on myocardial growth, vascularization, and fibrosis in relation to the expression of angiotensin II receptors (AT-R). We also characterized insulin signaling pathways believed to promote myocyte growth and interact with proliferative responses mediated by G protein-coupled receptors, and we assessed myocardial insulin receptor substrate-1 (IRS-1) and p110 alpha catalytic and p85 regulatory subunits of phospatidylinositol 3 kinase (PI3K), Akt, MEK, ERK1/2, and S6 kinase-1 (S6K1). Left ventricular (LV) geometry and performance were evaluated echocardiographically. Insulin decreased AT1a-R mRNA expression but increased protein levels and increased AT2-R mRNA and protein levels and phosphorylation of IRS-1 (Ser374/Tyr989), MEK1/2 (Ser218/Ser222), ERK1/2 (Thr202/Tyr204), S6K1 (Thr421/Ser424/Thr389), Akt (Thr308/Thr308), and PI3K p110 alpha but not of p85 (Tyr508). Insulin increased LV mass and relative wall thickness and reduced stroke volume and cardiac output. Histochemical examination demonstrated myocyte hypertrophy and increases in interstitial fibrosis. Metoprolol plus insulin prevented the increase in relative wall thickness, decreased fibrosis, increased LV mass, and improved function seen with insulin alone. Thus our data demonstrate that chronic hyperinsulinemia decreases AT1a-to-AT2 ratio and increases MEK-ERK1/2 and S6K1 pathway activity related to hypertrophy. These changes might be crucial for increased cardiovascular growth and fibrosis and signs of impaired LV function.

Mesh Headings (Keywords): 1-Phosphatidylinositol 3-Kinase, Animals, Blood Glucose, Blotting, Western, Body Weight, Electrocardiography, Female, Fibrosis, Gene Expression Regulation, Enzymologic, Heart, Hemodynamics, Hyperinsulinism, Immunohistochemistry, Insulin, Mitogen-Activated Protein Kinases, Organ Size, Proto-Oncogene Proteins c-akt, Rats, Rats, Sprague-Dawley, Receptors, Angiotensin, Receptors, G-Protein-Coupled, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Ventricular Function, Left


Check for Full Text / PubMed Unique Identifier (PMID): 16565309


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.